Introduction {#sec1-1}
============

Prevention is a crucial component for reduction of the global burden of cancer morbidity and mortality (Hui et al., 2013). It has been recently suggested that about one-third to half of the most commonly diagnosed cancers in the Western world, including breast cancer, could be avoided by practicing healthy lifestyles, such as eating a healthy diet rich in plant-based products (Ingram et al., 1997; Bouker and Hilakivi-Clarke, 2000; Hui et al., 2013). Indeed, diets containing plenty of fruits and vegetables have been related to a decreased risk of carcinogenesis, whereas polyphenolic flavonoids are thought to exert important chemopreventive effects (Iwasaki et al., 2009b; Hui et al., 2013; Magne Nde et al., 2015). However, although the cell culture investigations and animal experiments have suggested the anticancer action of different flavonoids, the results from epidemiological studies have identified limited, inconsistent and even controversial evidences about the associations between dietary flavonoid consumption and the risk of breast cancer in humans (Yamamoto et al., 2003; Adebamowo et al., 2005; Fink et al., 2007; Travis et al., 2008; Zhu et al., 2011; Hui et al., 2013; Touvier et al., 2013; Zamora-Ros et al., 2013; Wang et al., 2014; Magne Nde et al., 2015). One of the most compelling hints about the protective effects of flavonoids against carcinogenesis stems from the considerably lower rates of breast cancer cases in Asian countries compared to Western populations, and the increase in cancer prevalence along with migration of Asian women to the Western world and adoption of western dietary habits (Peeters et al., 2003; Verheus et al., 2007; Hedelin et al., 2008; Goodman et al., 2009; Lee et al., 2009; Magne Nde et al., 2015). The health benefits inherent for Asian region are attributed to the traditionally high intake of soy foods containing plenty of phytoestrogens, isoflavones (Peeters et al., 2003; Verheus et al., 2007; Hedelin et al., 2008; Taylor et al., 2009).

Flavonoids are polyphenolic substances found in different plant-origin food items and comprising more than 5,000 different compounds, divided to flavones (apigenin, luteolin), flavonols (quercetin, kaempferol, myricetin), flavanones (hesperetin, naringenin), flavanols or catechins (catechin, epicatechin, epicatechin 3-gallate, epigallocatechin, epigallocatechin 3-gallate, gallocatechin), isoflavones (genistein, daidzein, glycitein, biochanin A, formononetin) and anthocyanidins (Adebamowo et al., 2005; Zhang et al., 2009; Hui et al., 2013; Sak, 2014). The anticancer action of flavonoids has been a tempting research topic for recent decades and different activities, including antioxidant, antiinflammatory, antiproliferative, cytotoxic, antiangiogenic, and antimetastatic properties have been described for various flavonoids in numerous *in vitro* and *in vivo* experiments (Bosetti et al., 2005; Hui et al., 2013). Therefore, it is probable that cancer preventive and suppressive action of these plant secondary metabolites is derived from a variety of biological mechanisms affecting several biochemical pathways involved in tumorigenesis.

In the current review article, the epidemiological data about intake of flavonoids on breast cancer risk were compiled from literary sources, comprising the information on both the dietary consumption as well as biomarkers estimation (in plasma, serum, urine). For this aim, a PubMed search was carried out for articles published only in English language up to December 10th 2016 by using the following terms: "epidemiology" (or "epidemiological"), "cancer" (or "carcinogenesis", "tumor", "tumorigenesis"), and "flavonoid" (or "flavonoids"). All studies performed with breast cancers were further selected and references of extracted papers were carefully examined for identification of additional articles relevant for including in the current work. Moreover, both the case-control studies as well as prospective cohort studies were involved. These data are presented in Tables [1](#T1 T2){ref-type="table"}-[3](#T3){ref-type="table"} and are further discussed in the following subsections.

###### 

Epidemiological Case-Control Studies on Dietary Intake of Flavonoids and Breast Cancer Risk

  Flavonoid subclass   Certain compound   Study^[a](#t1f1){ref-type="table-fn"}^   Population                          Controls^[b](#t1f2){ref-type="table-fn"}^   Meno-pausal status   Cases/ controls   Intake comparison (low vs high, mg/day)^[c](#t1f3){ref-type="table-fn"}^   Multivariate-adjusted OR/RR/HR^[d](#t1f4){ref-type="table-fn"}^   P for trend^[e](#t1f5){ref-type="table-fn"}^   Comments^[f](#t1f6){ref-type="table-fn"}^                                                          Reference
  -------------------- ------------------ ---------------------------------------- ----------------------------------- ------------------------------------------- -------------------- ----------------- -------------------------------------------------------------------------- ----------------------------------------------------------------- ---------------------------------------------- -------------------------------------------------------------------------------------------------- -------------------------------
  Flavonoids                              LIBCSP                                   American                            PB                                                               1434/1440         0-34.5 vs ≥343.1 (Q5)                                                      0.88 (0.69-1.12)                                                  0.14                                           NA                                                                                                 Fink et al., 2007
  Flavonoids                              LIBCSP                                   American                            PB                                          Pre-                 457/487           0-34.5 vs ≥343.1 (Q5)                                                      1.12 (0.72-1.74)                                                  0.95                                           NA                                                                                                 Fink et al., 2007
  Flavonoids                              LIBCSP                                   American                            PB                                          Post-                977/953           0-34.5 vs ≥343.1 (Q5)                                                      0.75 (0.56-1.01)                                                  0.05\*                                         No effect modification by ER/PR status                                                             Fink et al., 2007
  Flavones                                LIBCSP                                   American                            PB                                                               1434/1440         0-0.04 vs ≥0.22 (Q5)                                                       0.73 (0.57-0.93)                                                  0.004\*                                        NA                                                                                                 Fink et al., 2007
  Flavones                                                                         Greek                                                                                                820/1548          0.3 vs 1.1 (Q5)                                                            0.87 (0.77-0.97)                                                  0.02\*                                         NA                                                                                                 Peterson et al., 2003
  Flavones                                                                         Italian                             HB                                                               2569/2588         (Q5)                                                                       0.81 (0.66-0.98)                                                  0.02\*                                         NA                                                                                                 Bosetti et al., 2005
  Flavones                                                                         Mexican                             HB                                                               141/141           0.1-1.6 vs 4.0-7.4 (T3)                                                    0.60 (0.27-1.37)                                                  0.241                                          NA                                                                                                 Torres-Sanchez et al., 2009
  Flavones                                LIBCSP                                   American                            PB                                          Pre-                 457/487           0-0.04 vs ≥0.22 (Q5)                                                       1.07 (0.70-1.65)                                                  0.94                                           NA                                                                                                 Fink et al., 2007
  Flavones                                                                         Mexican                             HB                                          Pre-                 68/69             0.1-1.6 vs 4.0-7.4 (T3)                                                    0.49 (0.19-1.29)                                                  0.152                                          NA                                                                                                 Torres-Sanchez et al., 2009
  Flavones                                LIBCSP                                   American                            PB                                          Post-                977/953           0-0.04 vs ≥0.22 (Q5)                                                       0.61 (0.45-0.83)                                                  \<0.001\*                                      No effect modification by ER/PR status                                                             Fink et al., 2007
  Flavones                                                                         Mexican                             HB                                          Post-                70/71             0.1-1.6 vs 4.0-7.4 (T3)                                                    0.29 (0.10-0.82)                                                  0.025\*                                        NA                                                                                                 Torres-Sanchez et al., 2009
  Flavonols                               LIBCSP                                   American                            PB                                                               1434/1440         0-3.7 vs ≥15.2 (Q5)                                                        0.75 (0.59-0.95)                                                  0.05\*                                         NA                                                                                                 Fink et al., 2007
  Flavonols                                                                        Greek                                                                                                820/1548          9.7 vs 30.6 (Q5)                                                           0.91 (0.78-1.06)                                                  0.22                                           NA                                                                                                 Peterson et al., 2003
  Flavonols                                                                        Italian                             HB                                                               2569/2588         (Q5)                                                                       0.80 (0.66-0.98)                                                  0.06                                           NA                                                                                                 Bosetti et al., 2005
  Flavonols                                                                        Mexican                             HB                                                               141/141           2.3-26.0 vs 36.8-72.0 (T3)                                                 0.48 (0.21-1.08)                                                  0.08                                           NA                                                                                                 Torres-Sanchez et al., 2009
  Flavonols                               LIBCSP                                   American                            PB                                          Pre-                 457/487           0-3.7 vs ≥15.2 (Q5)                                                        1.38 (0.88-2.15)                                                  0.92                                           NA                                                                                                 Fink et al., 2007
  Flavonols                                                                        Mexican                             HB                                          Pre-                 68/69             2.3-26.0 vs 36.8-72.0 (T3)                                                 0.49 (0.19-1.23)                                                  0.126                                          NA                                                                                                 Torres-Sanchez et al., 2009
  Flavonols                               LIBCSP                                   American                            PB                                          Post-                977/953           0-3.7 vs ≥15.2 (Q5)                                                        0.54 (0.40-0.73)                                                  \<0.001\*                                      No effect modification by ER/PR status                                                             Fink et al., 2007
  Flavonols                                                                        Mexican                             HB                                          Post-                70/71             2.3-26.0 vs 36.8-72.0 (T3)                                                 0.21 (0.07-0.60)                                                  0.004\*                                        NA                                                                                                 Torres-Sanchez et al., 2009
  Flavanones                              LIBCSP                                   American                            PB                                                               1434/1440         0-3.1 vs ≥40.4 (Q5)                                                        0.89 (0.70-1.12)                                                  0.64                                           NA                                                                                                 Fink et al., 2007
  Flavanones                                                                       Greek                                                                                                820/1548          9.1 vs 67.1 (Q5)                                                           0.96 (0.87-1.07)                                                  0.44                                           NA                                                                                                 Peterson et al., 2003
  Flavanones                                                                       Italian                             HB                                                               2569/2588         (Q5)                                                                       0.95 (0.79-1.15)                                                  0.49                                           NA                                                                                                 Bosetti et al., 2005
  Flavanones                              LIBCSP                                   American                            PB                                          Pre-                 457/487           0-3.1 vs ≥40.4 (Q5)                                                        0.80 (0.53-1.21)                                                  0.34                                           NA                                                                                                 Fink et al., 2007
  Flavanones                              LIBCSP                                   American                            PB                                          Post-                977/953           0-3.1 vs ≥40.4 (Q5)                                                        1.00 (0.75-1.34)                                                  0.87                                           No effect modification by ER/PR status                                                             Fink et al., 2007
  Flavanols                               LIBCSP                                   American                            PB                                                               1434/1440         0-5.1 vs ≥264.2 (Q5)                                                       0.85 (0.67-1.08)                                                  0.17                                           NA                                                                                                 Fink et al., 2007
  Flavanols                                                                        Greek                                                                                                820/1548          9.0 vs 45.2 (Q5)                                                           0.93 (0.78-1.11)                                                  0.43                                           NA                                                                                                 Peterson et al., 2003
  Flavanols                                                                        Italian                             HB                                                               2569/2588         (Q5)                                                                       0.86 (0.71-1.05)                                                  0.26                                           NA                                                                                                 Bosetti et al., 2005
  Flavanols                                                                        Mexican                             HB                                                               141/141           0.2-5.9 vs 10.6-4.59 (T3)                                                  0.80 (0.38-1.70)                                                  0.561                                          NA                                                                                                 Torres-Sanchez et al., 2009
  Flavanols                               LIBCSP                                   American                            PB                                          Pre-                 457/487           0-5.1 vs ≥264.2 (Q5)                                                       1.21 (0.78-1.86)                                                  0.87                                           NA                                                                                                 Fink et al., 2007
  Flavanols                                                                        Mexican                             HB                                          Pre-                 68/69             0.2-5.9 vs 10.6-45.9 (T3)                                                  1.22 (0.48-3.08)                                                  0.679                                          NA                                                                                                 Torres-Sanchez et al., 2009
  Flavanols                               LIBCSP                                   American                            PB                                          Post-                977/953           0-5.1 vs ≥264.2 (Q5)                                                       0.74 (0.55-0.99)                                                  0.06                                           No effect modification by ER/PR status                                                             Fink et al., 2007
  Flavanols                                                                        Mexican                             HB                                          Post-                70/71             0.2-5.9 vs 10.6-45.9 (T3)                                                  0.63 (0.25-1.62)                                                  0.349                                          NA                                                                                                 Torres-Sanchez et al., 2009
  Isoflavones                             LIBCSP                                   American                            PB                                                               1434/1440         0-0.31 vs ≥7.63 (Q5)                                                       0.95 (0.74-1.22)                                                  0.31                                           NA                                                                                                 Fink et al., 2007
  Isoflavones                                                                      American (multiethnic, non-Asian)   PB                                                               1272/1610         \<1.048 vs ≥2.775 (Q4)                                                     1.0 (0.79-1.3)                                                                                                   No effect modification by ethnicity (African American, Latina or White)                            Horn-Ross et al., 2001
  Isoflavones                                                                      Asian-American (multiethnic)        PB                                                               501/594           ≤1.79 vs \>12.68 /1000 kcal (Q4)                                           0.61 (0.39-0.97)                                                  0.04\*                                         NA                                                                                                 Wu et al., 2002
  Isoflavones                             OWDHS                                    Canadian                            PB                                                               3000/3370         0-0.082 vs 1.237-158.983 (Q5)                                              1.06 (0.87-1.30)                                                                                                 No effect modification by BMI strata (≤25, \>25)                                                   Cotterchio et al., 2008
  Isoflavones                             OWDHS                                    Canadian                            PB                                                               3024/3420         (Q4)                                                                       0.81 (0.71-0.94)                                                  \<0.01\*                                       Intake in adolescence                                                                              Thanos et al., 2006
  Isoflavones                             EPIC-Norfolk                             English                             PB                                                               244/938                                                                                      1.05 (0.90-1.21)                                                  0.54                                           NA                                                                                                 Ward et al., 2010
  Isoflavones                                                                      South Asian in England              PB                                                               240/477           \<0.125 vs ≥0.470 (Q4)                                                     0.58 (0.33-1.00)                                                  0.08                                           NA                                                                                                 dos Santos Silva et al., 2004
  Isoflavones                                                                      Greek                                                                                                820/1548          0.01 vs 0.8 (Q5)                                                           1.07 (0.97-1.18)                                                  0.17                                           NA                                                                                                 Peterson et al., 2003
  Isoflavones                                                                      Italian                             HB                                                               2569/2588         (Q5)                                                                       1.05 (0.86-1.29)                                                  0.78                                           NA                                                                                                 Bosetti et al., 2005
  Isoflavones                                                                      Korean                                                                                               358/360           \<8.5 vs ≥23.7 (Q4)                                                        0.81 (0.48-1.38)                                                  0.823                                          No effect modification by ER/PR status                                                             Cho et al., 2010
  Isoflavones                                                                      Japanese                            HB                                                               390/390           22.1 vs 69.1 (T3)                                                          0.83 (0.54-1.28)                                                  0.39                                           No effect modification by ER/PR status                                                             Iwasaki et al., 2009a
  Isoflavones                                                                      Japanese Brazilian                  HB                                                               81/81             4.7 vs 42.8 (T3)                                                           0.25 (0.09-0.68)                                                  \<0.01\*                                       No effect modification by ER/PR status                                                             Iwasaki et al., 2009a
  Isoflavones                                                                      Brazilian (non-Japanese)            HB                                                               379/379           0 vs 15.0 (non- vs consumers)                                              0.56 (0.35-0.90)                                                  \*                                             No effect modification by ER/PR status                                                             Iwasaki et al., 2009a
  Isoflavones                                                                      Chinese                             HB                                                               295/295           \<12.49 vs \>35.12 (Q4)                                                    0.52 (0.33-0.85)                                                  0.02\*                                         NA                                                                                                 Li et al., 2013
  Isoflavones                                                                      Chinese                             PB                                                               295/295           \<12.49 vs \>35.12 (Q4)                                                    0.45 (0.27-0.75)                                                  \<0.01\*                                       NA                                                                                                 Li et al., 2013
  Isoflavones                                                                      Chinese                             HB                                                               438/438           \<3.26 vs \>16.89 (Q4)                                                     0.54 (0.34-0.84)                                                  0.001\*                                        A significant inverse association for women with BMI\<25; no effect modification by ER/PR status   Zhang et al., 2010
  Isoflavones                                                                      Chinese                             HB                                                               183/192           \<7.56 vs \>28.83 (Q4)                                                     0.42 (0.22-0.80)                                                  0.031\*                                        A significant inverse association for ER+PR+ (not for ER-PR-, ER+PR- or ER-PR+) tumors             Zhu et al., 2011
  Isoflavones                                                                      Chinese                             HB                                                               /1009             \<7.78 vs \>25.40 (Q4)                                                                                                                       \*                                             No effect modification by ER/PR status                                                             Zhang et al., 2009
  Isoflavones                             LIBCSP                                   American                            PB                                          Pre-                 457/487           0-0.31 vs ≥7.63 (Q5)                                                       1.14 (0.76-1.72)                                                  0.56                                           NA                                                                                                 Fink et al., 2007
  Isoflavones                                                                      American (multiethnic, non-Asian)   PB                                          Pre-                 398/471           \<1.048 vs ≥2.775 (Q4)                                                     1.2 (0.75-2.0)                                                                                                   NA                                                                                                 Horn-Ross et al., 2001
  Isoflavones                             OWDHS                                    Canadian                            PB                                          Pre-                 930/1211          0-0.082 vs 1.237-158.983 (Q5)                                              0.96 (0.69-1.33)                                                                                                 No effect modification by BMI strata (≤25, \>25)                                                   Cotterchio et al., 2008
  Isoflavones                                                                      German                              PB                                          Pre-                 278/666           (Q4)                                                                       0.85 (0.54-1.33)                                                  0.229                                          NA                                                                                                 Linseisen et al., 2004
  Isoflavones                                                                      Korean                                                                          Pre-                 358/360           \<8.5 vs ≥23.7 (Q4)                                                        1.36 (0.64-2.91)                                                  0.209                                          No effect modification by ER/PR status                                                             Cho et al., 2010
  Isoflavones                             HERPACC                                  Japanese                            HB                                          Pre-                 79/414            7.61 vs 18.47 /1000 kcal (T3)                                              0.44 (0.22-0.89)                                                  0.02\*                                         NA                                                                                                 Hirose et al., 2005
  Isoflavones                                                                      Japanese                            HB                                          Pre-                 178/137           22.1 vs 69.1 (T3)                                                          1.35 (0.72-2.54)                                                  0.41                                           No effect modification by ER/PR status                                                             Iwasaki et al., 2009a
  Isoflavones                                                                      Japanese Brazilian                  HB                                          Pre-                 25/24             8.0 vs 35.0 (two medians)                                                  0.17 (0.03-0.84)                                                  \*                                             NA                                                                                                 Iwasaki et al., 2009a
  Isoflavones                                                                      Brazilian (non-Japanese)            HB                                          Pre-                 161/145           0 vs 15.0 (non- vs consumers)                                              0.54 (0.26-1.13)                                                                                                 NA                                                                                                 Iwasaki et al., 2009a
  Isoflavones                                                                      Chinese                             HB                                          Pre-                 306/295           (Q4)                                                                       0.46 (0.26-0.82)                                                  \<0.001\*                                      NA                                                                                                 Zhang et al., 2010
  Isoflavones                                                                      Chinese                             HB                                          Pre-                 /671              \<7.78 vs \>25.40 (Q4)                                                                                                                       \*                                             No effect modification by ER/PR status                                                             Zhang et al., 2009
  Isoflavones                                                                      Chinese                             HB                                          Pre-                 183/192           \<7.56 vs \>28.83 (Q4)                                                     0.66 (0.31-1.07)                                                                                                 NA                                                                                                 Zhu et al., 2011
  Isoflavones                             LIBCSP                                   American                            PB                                          Post-                977/953           0-0.31 vs ≥7.63 (Q5)                                                       1.02 (0.76-1.38)                                                  0.72                                           No effect modification by ER/PR status                                                             Fink et al., 2007
  Isoflavones                                                                      American (multiethnic, non-Asian)   PB                                          Post-                826/1077          \<1.048 vs ≥2.775 (Q4)                                                     0.96 (0.71-1.3)                                                                                                  NA                                                                                                 Horn-Ross et al., 2001
  Isoflavones                             OWDHS                                    Canadian                            PB                                          Post-                2067/2154         0-0.082 vs 1.237-158.983 (Q5)                                              1.09 (0.83-1.41)                                                                                                 No effect modification by BMI strata (≤25, \>25)                                                   Cotterchio et al., 2008
  Isoflavones                                                                      Chinese                             HB                                          Post-                132/143           (Q4)                                                                       0.66 (0.30-1.44)                                                  0.281                                          NA                                                                                                 Zhang et al., 2010
  Isoflavones                                                                      Korean                                                                          Post-                358/360           \<8.5 vs ≥23.7 (Q4)                                                        0.33 (0.15-0.72)                                                  0.016\*                                        Inverse association for women with ER+PR+ (not ER-PR-) tumor                                       Cho et al., 2010
  Isoflavones                             HERPACC                                  Japanese                            HB                                          Post-                88/440            8.69 vs 22.26 /1000 kcal (T3)                                              0.58 (0.30-1.10)                                                  0.09                                           NA                                                                                                 Hirose et al., 2005
  Isoflavones                                                                      Japanese                            HB                                          Post-                212/253           22.1 vs 69.1 (T3)                                                          0.62 (0.38-1.01)                                                  0.06                                           No effect modification by ER/PR status                                                             Iwasaki et al., 2009a
  Isoflavones                                                                      Japanese Brazilian                  HB                                          Post-                56/57             8.0 vs 35.0 (two medians)                                                  0.84 (0.37-1.92)                                                                                                 NA                                                                                                 Iwasaki et al., 2009a
  Isoflavones                                                                      Brazilian (non-Japanese)            HB                                          Post-                218/234           0 vs 15.0 (non- vs consumers)                                              0.58 (0.33-1.03)                                                                                                 NA                                                                                                 Iwasaki et al., 2009a
  Isoflavones                                                                      Chinese                             HB                                          Post- or peri-       183/192           \<7.56 vs \>28.83 (Q4)                                                     0.57 (0.29-0.83)                                                  \*                                             NA                                                                                                 Zhu et al., 2011
  Isoflavones                                                                      Chinese                             HB                                          Post-                /338              \<7.78 vs \>25.40 (Q4)                                                                                                                       \*                                             No effect modification by ER/PR status                                                             Zhang et al., 2009
  Isoflavones          Genistein                                                   American (multiethnic, non-Asian)   PB                                                               1272/1610         \<0.480 vs ≥1.440 (Q4)                                                     0.92 (0.72-1.2)                                                                                                  NA                                                                                                 Horn-Ross et al., 2001
  Isoflavones          Genistein          EPIC-Norfolk                             English                             PB                                                               244/938                                                                                      1.04 (0.90-1.19)                                                  0.63                                           NA                                                                                                 Ward et al., 2010
  Isoflavones          Genistein                                                   South Asian in England              PB                                                               240/477           \<0 078 vs ≥.0232 (Q4)                                                     0.62 (0.36-1.06)                                                  0.1                                            NA                                                                                                 dos Santos Silva et al., 2004
  Isoflavones          Genistein          JPHC                                     Japanese                            PB                                                               144/288           (Q4)                                                                       0.58 (0.29-1.18)                                                  0.21                                           NA                                                                                                 Iwasaki et al., 2008
  Isoflavones          Genistein                                                   Chinese                             HB                                                               295/295           \<8.46 vs \>25.44 (Q4)                                                     0.34 (0.19-0.60)                                                  \<0.01\*                                       NA                                                                                                 Li et al., 2013
  Isoflavones          Genistein                                                   Chinese                             PB                                                               295/295           \<8.46 vs \>25.44 (Q4)                                                     0.28 (0.15-0.52)                                                  \<0.01\*                                       NA                                                                                                 Li et al., 2013
  Isoflavones          Genistein                                                   Chinese                             HB                                                               /1009             \<4.27 vs \>14.18 (Q4)                                                                                                                       \*                                             No effect modification by ER/PR status                                                             Zhang et al., 2009
  Isoflavones          Genistein                                                   German                              PB                                          Pre-                 278/666           (Q4)                                                                       0.47 (0.29-0.74)                                                  0.002\*                                        NA                                                                                                 Linseisen et al., 2004
  Isoflavones          Genistein          JPHC                                     Japanese                            PB                                          Pre-                 59/118            (Q4)                                                                       0.62 (0.21-1.84)                                                  0.43                                           NA                                                                                                 Iwasaki et al., 2008
  Isoflavones          Genistein                                                   Chinese                             HB                                          Pre-                 /671              \<4.27 vs \>14.18 (Q4)                                                                                                                       \*                                             No effect modification by ER/PR status                                                             Zhang et al., 2009
  Isoflavones          Genistein          JPHC                                     Japanese                            PB                                          Post-                80/160            (Q4)                                                                       0.52 (0.19-1.42)                                                  0.31                                           NA                                                                                                 Iwasaki et al., 2008
  Isoflavones          Genistein                                                   Chinese                             HB                                          Post-                /338              \<4.27 vs \>14.18 (Q4)                                                                                                                       \*                                             No effect modification by ER/PR status                                                             Zhang et al., 2009
  Isoflavones          Daidzein                                                    American (multiethnic, non-Asian)   PB                                                               1272/1610         \<0.473 vs ≥1.223 (Q4)                                                     1.1 (0.85-1.4)                                                                                                   NA                                                                                                 Horn-Ross et al., 2001
  Isoflavones          Daidzein           EPIC-Norfolk                             English                             PB                                                               244/938                                                                                      1.03 (0.89-1.18)                                                  0.7                                            NA                                                                                                 Ward et al., 2010
  Isoflavones          Daidzein                                                    German                              PB                                          Pre-                 278/666           (Q4)                                                                       0.62 (0.40-0.95)                                                  0.065                                          NA                                                                                                 Linseisen et al., 2004
  Isoflavones          Daidzein                                                    South Asian in England              PB                                                               240/477           \<0 078 vs ≥.0232 (Q4)                                                     0.57 (0.33-0.99)                                                  0.09                                           NA                                                                                                 dos Santos Silva et al., 2004
  Isoflavones          Daidzein           JPHC                                     Japanese                            PB                                                               144/288           (Q4)                                                                       0.67 (0.33-1.39)                                                  0.34                                           NA                                                                                                 Iwasaki et al., 2008
  Isoflavones          Daidzein                                                    Chinese                             HB                                                               295/295           \<6.33 vs \>19.47 (Q4)                                                     0.38 (0.22-0.64)                                                  \<0.01\*                                       NA                                                                                                 Li et al., 2013
  Isoflavones          Daidzein                                                    Chinese                             PB                                                               295/295           \<6.33 vs \>19.47 (Q4)                                                     0.32 (0.18-0.56)                                                  \<0.01\*                                       NA                                                                                                 Li et al., 2013
  Isoflavones          Daidzein                                                    Chinese                             HB                                                               /1009             \<2.98 vs \>9.76 (Q4)                                                                                                                        \*                                             No effect modification by ER/PR status                                                             Zhang et al., 2009
  Isoflavones          Daidzein           JPHC                                     Japanese                            PB                                          Pre-                 59/118            (Q4)                                                                       0.67 (0.22-2.03)                                                  0.53                                           NA                                                                                                 Iwasaki et al., 2008
  Isoflavones          Daidzein                                                    Chinese                             HB                                          Pre-                 /671              \<2.98 vs \>9.76 (Q4)                                                                                                                        \*                                             No effect modification by ER/PR status                                                             Zhang et al., 2009
  Isoflavones          Daidzein           JPHC                                     Japanese                            PB                                          Post-                80/160            (Q4)                                                                       0.64 (0.23-1.72)                                                  0.43                                           NA                                                                                                 Iwasaki et al., 2008
  Isoflavones          Daidzein                                                    Chinese                             HB                                          Post-                /338              \<2.98 vs \>9.76 (Q4)                                                                                                                        \*                                             No effect modification by ER/PR status                                                             Zhang et al., 2009
  Isoflavones          Biochanin A                                                 American (multiethnic, non-Asian)   PB                                                               1272/1610         \<0.022 vs ≥0.083 (Q4)                                                     1.2 (0.85-1.5)                                                                                                   NA                                                                                                 Horn-Ross et al., 2001
  Isoflavones          Biochanin A        EPIC-Norfolk                             English                             PB                                                               244/938                                                                                      1.10 (0.90-1.34)                                                  0.36                                           NA                                                                                                 Ward et al., 2010
  Isoflavones          Biochanin A                                                 German                              PB                                          Pre-                 278/666           (Q4)                                                                       0.85 (0.53-1.38)                                                  0.747                                          NA                                                                                                 Linseisen et al., 2004
  Isoflavones          Formononetin                                                American (multiethnic, non-Asian)   PB                                                               1272/1610         \<0.009 vs ≥0.040 (Q4)                                                     1.2 (0.96-1.5)                                                                                                   NA                                                                                                 Horn-Ross et al., 2001
  Isoflavones          Formononetin       EPIC-Norfolk                             English                             PB                                                               244/938                                                                                      0.94 (0.81-1.09)                                                  0.44                                           NA                                                                                                 Ward et al., 2010
  Isoflavones          Formononetin                                                German                              PB                                          Pre-                 278/666           (Q4)                                                                       1.14 (0.72-1.82)                                                  0.395                                          NA                                                                                                 Linseisen et al., 2004
  Isoflavones          Glycitein          EPIC-Norfolk                             English                             PB                                                               244/938                                                                                      0.96 (0.80-1.14)                                                  0.63                                           NA                                                                                                 Ward et al., 2010
  Isoflavones          Glycitein                                                   Chinese                             HB                                                               295/295           \<0.38 vs \>1.46 (Q4)                                                      0.66 (0.40-1.08)                                                  0.12                                           NA                                                                                                 Li et al., 2013
  Isoflavones          Glycitein                                                   Chinese                             PB                                                               295/295           \<0.38 vs \>1.46 (Q4)                                                      0.55 (0.33-0.92)                                                  0.02\*                                         NA                                                                                                 Li et al., 2013
  Isoflavones          Glycitein                                                   Chinese                             HB                                                               /1009             \<1.19 vs \>6.32 (Q4)                                                                                                                        \*                                             No effect modification by ER/PR status                                                             Zhang et al., 2009
  Isoflavones          Glycitein                                                   Chinese                             HB                                          Pre-                 /671              \<1.19 vs \>6.32 (Q4)                                                                                                                        \*                                             No effect modification by ER/PR status                                                             Zhang et al., 2009
  Isoflavones          Glycitein                                                   Chinese                             HB                                          Post-                /338              \<1.19 vs \>6.32 (Q4)                                                                                                                        \*                                             No effect modification by ER/PR status                                                             Zhang et al., 2009
  Isoflavones          Equol              EPIC-Norfolk                             English                             PB                                                               244/938                                                                                      1.04 (0.86-1.26)                                                  0.7                                            NA                                                                                                 Ward et al., 2010
  Anthocyanidins                          LIBCSP                                   American                            PB                                                               1434/1440         0-0.04 vs ≥4.20 (Q5)                                                       0.91 (0.72-1.15)                                                  0.27                                           NA                                                                                                 Fink et al., 2007
  Anthocyanidins                                                                   Greek                               Case-control                                                     820/1548          5.1 vs 81.4 (Q5)                                                           0.94 (0.81-1.09)                                                  0.39                                           NA                                                                                                 Peterson et al., 2003
  Anthocyanidins                                                                   Italian                             HB                                                               2569/2588         (Q5)                                                                       1.09 (0.87-1.36)                                                  0.38                                           NA                                                                                                 Bosetti et al., 2005
  Anthocyanidins                          LIBCSP                                   American                            PB                                          Pre-                 457/487           0-0.04 vs ≥4.20 (Q5)                                                       1.08 (0.71-1.63)                                                  0.81                                           NA                                                                                                 Fink et al., 2007
  Anthocyanidins                          LIBCSP                                   American                            PB                                          Post-                977/953           0-0.04 vs ≥4.20 (Q5)                                                       0.85 (0.64-1.14)                                                  0.23                                           No effect modification by ER/PR status                                                             Fink et al., 2007

EPIC; The European Prospective Investigation into Cancer and Nutrition; HERPACC, The Hospital-Based Epidemiologic Research Program at Aichi Cancer Center; JPHC, The Japan Public Health Center-based prospective study; LIBCSP, The Long Island Breast Cancer Study Project; OWDHS; The Ontario Women\`s Diet and Health Study;

HB; hospital-based; PB, population-based;

T3; tertiles; Q4, quartiles; Q5, quintiles;

OR, odds ratio; RR, relative risk; HR, hazard ratio;

Statistically significant effects (p for trend \<0.05) are marked by asterisk;

ER, estrogen receptor; PR, progesterone receptor; NA, not applicable

###### 

Epidemiological Prospective Cohort Studies on Dietary Intake of Flavonoids and Breast Cancer Risk

  Flavonoid subclass   Certain compound   Study^[a](#t2f1){ref-type="table-fn"}^   Population                          Median follow-up (years)   Meno-pausal status in baseline   Cases/ cohort   Intake comparison (low vs high, mg/day)^b^   Multivariate-adjusted OR/RR/HR^[c](#t2f2){ref-type="table-fn"}^   P for trend^[d](#t2f3){ref-type="table-fn"}^   Comments^[e](#t2f4){ref-type="table-fn"}^                                                                                                                Reference
  -------------------- ------------------ ---------------------------------------- ----------------------------------- -------------------------- -------------------------------- --------------- -------------------------------------------- ----------------------------------------------------------------- ---------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------
  Flavonoids                              WHS                                      American                            11.5                                                        1351/38408      (Q5)                                         1.03 (0.85-1.25)                                                  0.79                                           NA                                                                                                                                                       Wang et al., 2009
  Flavonoids                              EPIC                                     Women from ten European countries   11.5                                                        11576/334850    \<176.0 vs \>654.0 (Q5)                      0.97 (0.90-1.04)                                                  0.591                                          No effect modification by ER/PR status                                                                                                                   Zamora-Ros et al., 2013
  Flavonoids                              NLCS                                     Dutch                               4.3                                                         605/3123        13.5 vs 44.6 (Q5)                            1.02 (0.72-1.44)                                                  0.74                                           NA                                                                                                                                                       Goldbohm et al., 1998
  Flavonoids                              FMC                                      Finnish                             24                                                          87/9959         \<2.4 vs \>5.5 (Q4)                          0.72 (0.36-1.48)                                                                                                 NA                                                                                                                                                       Knekt et al., 1997
  Flavonoids                              FMC                                      Finnish                             30                                                          125/4647        8.5 vs 39.5 (Q4)                             1.23 (0.72-2.10)                                                  0.53                                           NA                                                                                                                                                       Knekt et al., 2002
  Flavonoids                              SU.VI.MAX                                French                              12.6                                                        59/2011         294.2 vs 631.7 (Q4)                          0.35 (0.17-0.75)                                                  0.02\*                                         Non-to-low alcohol users; increased risk in higher drinkers                                                                                              Touvier et al., 2013
  Flavonoids                              EPIC                                     Women from ten European countries   11.5                       Pre-                             2827/334850     \<176.0 vs \>654.0 (Q5)                      0.98 (0.84-1.15)                                                  0.656                                          NA                                                                                                                                                       Zamora-Ros et al., 2013
  Flavonoids                              CPS-II                                   American                            8.5                        Post-                            2116/56630      ≤119 vs \>364-2063 (Q5)                      0.95 (0.83-1.08)                                                  0.66                                           No effect modification by ER status                                                                                                                      Wang et al., 2014
  Flavonoids                              EPIC                                     Women from ten European countries   11.5                       Post-                            5872/334850     \<176.0 vs \>654.0 (Q5)                      0.96 (0.86-1.06)                                                  0.622                                          NA                                                                                                                                                       Zamora-Ros et al., 2013
  Flavonoids                              RS                                       Dutch                               17                         Post-                            199/3209        18.07 vs 40.46 (T3)                          0.93 (0.64-1.34)                                                                                                 NA                                                                                                                                                       Pantavos et al., 2015
  Flavones                                EPIC                                     Women from ten European countries   11.5                                                        11576/334850    \<1.12 vs \>4.88 (Q5)                        0.99 (0.91-1.07)                                                  0.729                                          No effect modification by ER/PR status                                                                                                                   Zamora-Ros et al., 2013
  Flavones                                SU.VI.MAX                                French                              12.6                                                        152/4141        23.5 vs 30.9 (Q4)                            1.53 (1.00-2.36)                                                  0.02\*                                         NA                                                                                                                                                       Touvier et al., 2013
  Flavones                                EPIC                                     Women from ten European countries   11.5                       Pre-                             2827/334850     \<1.12 vs \>4.88 (Q5)                        0.86 (0.73-1.02)                                                  0.162                                          NA                                                                                                                                                       Zamora-Ros et al., 2013
  Flavones                                CPS-II                                   American                            8.5                        Post-                            2116/56630      ≤0.6 vs \>2.1-8.2 (Q5)                       0.88 (0.76-1.01)                                                  0.04\*                                         NA                                                                                                                                                       Wang et al., 2014
  Flavones                                EPIC                                     Women from ten European countries   11.5                       Post-                            5872/334850     \<1.12 vs \>4.88 (Q5)                        1.10 (0.98-1.23)                                                  0.12                                           NA                                                                                                                                                       Zamora-Ros et al., 2013
  Flavonols                               EPIC                                     Women from ten European countries   11.5                                                        11576/334850    \<12.8 vs \>39.8 (Q5)                        0.96 (0.88-1.03)                                                  0.259                                          No effect modification by ER/PR status                                                                                                                   Zamora-Ros et al., 2013
  Flavonols                               SU.VI.MAX                                French                              12.6                                                        59/2011         33.0 vs 59.8 (Q4)                            0.36 (0.18-0.74)                                                  0.002\*                                        Non-to-low alcohol users                                                                                                                                 Touvier et al., 2013
  Flavonols                               NHS II                                   American                            8                          Pre-                             710/90638       6.8 vs 43.8 (Q5)                             1.05 (0.83-1.34)                                                  0.96                                           NA                                                                                                                                                       Adebamowo et al., 2005
  Flavonols                               EPIC                                     Women from ten European countries   11.5                       Pre-                             2827/334850     \<12.8 vs \>39.8 (Q5)                        0.91 (0.78-1.06)                                                  0.316                                          NA                                                                                                                                                       Zamora-Ros et al., 2013
  Flavonols                               CPS-II                                   American                            8.5                        Post-                            2116/56630      ≤8.3 vs \>20.8-83.1 (Q5)                     0.92 (0.81-1.06)                                                  0.41                                           No effect modification by ER status                                                                                                                      Wang et al., 2014
  Flavonols                               EPIC                                     Women from ten European countries   11.5                       Post-                            5872/334850     \<12.8 vs \>39.8 (Q5)                        1.00 (0.90-1.12)                                                  0.893                                          NA                                                                                                                                                       Zamora-Ros et al., 2013
  Flavonols            Kaempferol         NLCS                                     Dutch                               4.3                                                         605/3123        2.6 vs 12.9 (Q5)                             1.02 (0.72-1.45)                                                  0.286                                          NA                                                                                                                                                       Goldbohm et al., 1998
  Flavonols            Kaempferol         FMC                                      Finnish                             30                                                          125/4647        0.2 vs 0.9 (Q4)                              0.87 (0.53-1.41)                                                  0.7                                            NA                                                                                                                                                       Knekt et al., 2002
  Flavonols            Kaempferol         NHS II                                   American                            8                          Pre-                             710/90638       0.8 vs 12.9 (Q5)                             1.01 (0.80-1.27)                                                  0.91                                           NA                                                                                                                                                       Adebamowo et al., 2005
  Flavonols            Myricetin          FMC                                      Finnish                             30                                                          125/4647        0.03 vs 0.20 (Q4)                            0.95 (0.57-1.60)                                                  0.63                                           NA                                                                                                                                                       Knekt et al., 2002
  Flavonols            Myricetin          NHS II                                   American                            8                          Pre-                             710/90638       0.09 vs 2.62 (Q5)                            0.99 (0.78-1.26)                                                  0.35                                           NA                                                                                                                                                       Adebamowo et al., 2005
  Flavonols            Quercetin          NLCS                                     Dutch                               4.3                                                         605/3123        8.9 vs 30.8 (Q5)                             1.00 (0.70-1.41)                                                  0.957                                          NA                                                                                                                                                       Goldbohm et al., 1998
  Flavonols            Quercetin          FMC                                      Finnish                             30                                                          125/4647        1.8 vs 4.7 (Q4)                              0.62 (0.37-1.03)                                                  0.25                                           NA                                                                                                                                                       Knekt et al., 2002
  Flavonols            Quercetin          NHS II                                   American                            8                          Pre-                             710/90638       5.3 vs 30.1 (Q5)                             1.05 (0.83-1.33)                                                  0.81                                           NA                                                                                                                                                       Adebamowo et al., 2005
  Flavanones                              EPIC                                     Women from ten European countries   11.5                                                        11576/334850    \<6.2 vs \>33.0 (Q5)                         0.99 (0.93-1.06)                                                  0.562                                          No effect modification by ER/PR status                                                                                                                   Zamora-Ros et al., 2013
  Flavanones                              SU.VI.MAX                                French                              12.6                                                        59/2011         18.6 vs 28.3 (Q4)                            1.27 (0.65-2.48)                                                  0.62                                           Non-to-low alcohol users; no effect modification for higher drinkers                                                                                     Touvier et al., 2013
  Flavanones                              EPIC                                     Women from ten European countries   11.5                       Pre-                             2827/334850     \<6.2 vs \>33.0 (Q5)                         1.02 (0.89-1.18)                                                  0.283                                          NA                                                                                                                                                       Zamora-Ros et al., 2013
  Flavanones                              CPS-II                                   American                            8.5                        Post-                            2116/56630      ≤6.5 vs \>34.0-162 (Q5)                      1.04 (0.90-1.19)                                                  0.34                                           No effect modification by ER status                                                                                                                      Wang et al., 2014
  Flavanones                              EPIC                                     Women from ten European countries   11.5                       Post-                            5872/334850     \<6.2 vs \>33.0 (Q5)                         1.04 (0.95-1.15)                                                  0.401                                          NA                                                                                                                                                       Zamora-Ros et al., 2013
  Flavanones           Hesperetin         FMC                                      Finnish                             30                                                          125/4647        3.2 vs 26.8 (Q4)                             1.08 (0.63-1.86)                                                  0.93                                           NA                                                                                                                                                       Knekt et al., 2002
  Flavanones           Naringenin         FMC                                      Finnish                             30                                                          125/4647        0.9 vs 7.7 (Q4)                              1.14 (0.67-1.94)                                                  0.82                                           NA                                                                                                                                                       Knekt et al., 2002
  Flavanols                               EPIC                                     Women from ten European countries   11.5                                                        11576/334850    \<18.2 vs \>379.8 (Q5)                       1.01 (0.93-1.09)                                                  0.856                                          No effect modification by ER/PR status                                                                                                                   Zamora-Ros et al., 2013
  Flavanols                               SU.VI.MAX                                French                              12.6                                                        59/2011         61.2 vs 151.5 (Q4)                           0.48 (0.22-1.05)                                                  0.02\*                                         Non-to-low alcohol users; increased risk in higher drinkers                                                                                              Touvier et al., 2013
  Flavanols                               EPIC                                     Women from ten European countries   11.5                       Pre-                             2827/334850     \<18.2 vs \>379.8 (Q5)                       0.96 (0.82-1.13)                                                  0.7                                            NA                                                                                                                                                       Zamora-Ros et al., 2013
  Flavanols                               CPS-II                                   American                            8.5                        Post-                            2116/56630      ≤9.0 vs \>36.7-410 (Q5)                      0.98 (0.86-1.12)                                                  0.56                                           NA                                                                                                                                                       Wang et al., 2014
  Flavanols                               IWHS                                     American                            13                         Post-                            1069/34651      3.6 vs 75.1 (Q5)                             1.04 (0.84-1.28)                                                  1                                              NA                                                                                                                                                       Arts et al., 2002
  Flavanols                               EPIC                                     Women from ten European countries   11.5                       Post-                            5872/334850     \<18.2 vs \>379.8 (Q5)                       1.00 (0.90-1.11)                                                  0.932                                          NA                                                                                                                                                       Zamora-Ros et al., 2013
  Isoflavones                             MEC                                      American, Hawaiian (multiethnic)    13.7                                                        4769/84450      1.7 vs 29.6 (Q4)                             0.96 (0.85-1.08)                                                  0.4                                            A weak protective association for Japanese American; no effect modification by ER status                                                                 Morimoto et al., 2014
  Isoflavones                             EPIC                                     Women from ten European countries   11.5                                                        11576/334850    \<0.22 vs \>1.36 (Q5)                        1.00 (0.91-1.10)                                                  0.734                                          No effect modification by ER/PR status                                                                                                                   Zamora-Ros et al., 2013
  Isoflavones                             EPIC-Oxford                              British                             7.4                                                         585/37643       \<10 vs \>20                                 1.17 (0.79-1.71)                                                  0.36                                           No effect modification for non-HRT users                                                                                                                 Travis et al., 2008
  Isoflavones                             EPIC-Dutch                               Dutch                               5.2                                                         280/15555       0.19 vs 0.77 (Q4)                            0.98 (0.65-1.48)                                                  0.92                                           NA                                                                                                                                                       Keinan-Boker et al., 2004
  Isoflavones                             WLH-Swedish                              Swedish                             13                                                          1014/45448      (Q4)                                         0.98 (0.83-1.17)                                                                                                 No effect modification by age strata (\<50, ≥50 y)                                                                                                       Hedelin et al., 2008
  Isoflavones                             TS                                       Japanese                            15.5                                                        172/15607       18.6 vs 70.6 (Q4)                            0.67 (0.44-1.03)                                                  0.25                                           NA                                                                                                                                                       Wada et al., 2013
  Isoflavones                             SWHS                                     Chinese                             7.4                                                         594/73223       11.23 vs 54.97 (Q5)                          0.81 (0.61-1.07)                                                  0.091                                          NA                                                                                                                                                       Lee et al., 2009
  Isoflavones                             SCHS                                     Singapore Chinese                                                                               629/35303       \<10.6 vs ≥10.6 /1000 kcal                   0.82 (0.70-0.97)                                                  0.019\*                                        Strong association for women with \>10 y follow-up                                                                                                       Wu et al., 2008
  Isoflavones                             EPIC                                     Women from ten European countries   11.5                       Pre-                             2827/334850     \<0.22 vs \>1.36 (Q5)                        0.94 (0.77-1.16)                                                  0.351                                          NA                                                                                                                                                       Zamora-Ros et al., 2013
  Isoflavones                             EPIC-Oxford                              British                             7.4                        Pre-                             196/37643       \<10 vs \>10                                 1.31 (0.95-1.81)                                                  0.11                                           NA                                                                                                                                                       Travis et al., 2008
  Isoflavones                             E3N                                      French                              12                         Pre-                             402/26868       0.001-0.022 vs 0.036-0.112 (Q4)              1.00 (0.76-1.31)                                                  0.48                                           NA                                                                                                                                                       Touillaud MS et al 2006 15 2574-6)
  Isoflavones                             TS                                       Japanese                            15.5                       Pre-                             38/5926         17.8 vs 68.5 (Q4)                            1.52 (0.63-3.65)                                                  0.14                                           NA                                                                                                                                                       Wada et al., 2013
  Isoflavones                             SWHS                                     Chinese                             7.4                        Pre-                             305/73223       11.23 vs 54.97 (Q5)                          0.44 (0.26-0.73)                                                  \<0.001\*                                      NA                                                                                                                                                       Lee et al., 2009
  Isoflavones                             SCHS                                     Singapore Chinese                                              Pre-                             190/35303       \<10.6 vs ≥10.6 /1000 kcal                   1.04 (0.77-1.40)                                                  0.82                                           NA                                                                                                                                                       Wu et al., 2008
  Isoflavones                             CPS-II                                   American                            8.5                        Post-                            2116/56630      ≤0.026 vs \>0.093-45.0 (Q5)                  1.04 (0.91-1.20)                                                  0.64                                           No effect modification by ER status                                                                                                                      Wang et al., 2014
  Isoflavones                             MEC                                      American, Hawaiian (multiethnic)    13.7                       Post-                            4112/84450      1.7 vs 29.6 (Q4)                             0.98 (0.86-1.12)                                                  0.56                                           NA                                                                                                                                                       Morimoto et al., 2014
  Isoflavones                             EPIC                                     Women from ten European countries   11.5                       Post-                            5872/334850     \<0.22 vs \>1.36 (Q5)                        1.00 (0.87-1.14)                                                  0.702                                          NA                                                                                                                                                       Zamora-Ros et al., 2013
  Isoflavones                             EPIC-Oxford                              British                             7.4                        Post-                            310/37643       \<10 vs \>10                                 0.95 (0.66-1.38)                                                  0.8                                            NA                                                                                                                                                       Travis et al., 2008
  Isoflavones                             TS                                       Japanese                            15.5                       Post-                            134/15264       18.7 vs 70.6 (Q4)                            0.52 (0.32-0.85)                                                  0.046\*                                        Stronger inverse association for women with BMI\<25, never smokers, drinker                                                                              Wada et al., 2013
  Isoflavones                             SWHS                                     Chinese                             7.4                        Post-                            289/73223       11.23 vs 54.97 (Q5)                          1.09 (0.78-1.52)                                                  0.8                                            NA                                                                                                                                                       Lee et al., 2009
  Isoflavones                             SCHS                                     Singapore Chinese                                              Post-                            439/35303       \<10.6 vs ≥10.6 /1000 kcal                   0.74 (0.61-0.90)                                                  0.003\*                                        Strong association for women with \>10 y follow-up; a significant association for women with BMI\>24 (not ≤24); no effect modification by ER/PR status   Wu et al., 2008
  Isoflavones          Genistein          CTS                                      American                            2                                                           711/111526      (Q5)                                         1.0 (0.7-1.3)                                                     0.9                                            NA                                                                                                                                                       Horn-Ross et al., 2002
  Isoflavones          Genistein          WLH -Swedish                             Swedish                             13                                                          1014/45448      (Q4)                                         1.01 (0.84-1.20)                                                                                                 No effect modification by age strata (\<50, ≥50 y)                                                                                                       Hedelin et al., 2008
  Isoflavones          Genistein          JPHC                                     Japanese                            10                                                          179/21852       6.9±2.6 vs 25.3±2.2 (Q4)                     0.46 (0.25-0.84)                                                  0.043\*                                        NA                                                                                                                                                       Yamamoto et al., 2003
  Isoflavones          Genistein          JPHC                                     Japanese                            10                         Pre-                             89/21852        (Q4)                                         0.66 (0.25-1.7)                                                   0.97                                           NA                                                                                                                                                       Yamamoto et al., 2003
  Isoflavones          Genistein          JPHC                                     Japanese                            10                         Post-                            87/21852        (Q4)                                         0.32 (0.14-0.71)                                                  0.006\*                                        NA                                                                                                                                                       Yamamoto et al., 2003
  Isoflavones          Daidzein           CTS                                      American                            2                                                           711/111526      (Q5)                                         0.9 (0.7-1.2)                                                     0.6                                            NA                                                                                                                                                       Horn-Ross et al., 2002
  Isoflavones          Daidzein           WLH-Swedish                              Swedish                             13                                                          1014/45448      (Q4)                                         1.07 (0.90-1.28)                                                                                                 No effect modification by age strata (\<50, ≥50 y)                                                                                                       Hedelin et al., 2008
  Isoflavones          Biochanin A        CTS                                      American                            2                                                           711/111526      (Q5)                                         1.0 (0.8-1.3)                                                     0.7                                            NA                                                                                                                                                       Horn-Ross et al., 2002
  Isoflavones          Formononetin       CTS                                      American                            2                                                           711/111526      (Q5)                                         1.1 (0.8-1.4)                                                     0.4                                            NA                                                                                                                                                       Horn-Ross et al., 2002
  Anthocyanidins                          EPIC                                     Women from ten European countries   11.5                                                        11576/334850    \<12.1 vs \>43.6 (Q5)                        1.02 (0.94-1.10)                                                  0.56                                           No effect modification by ER/PR status                                                                                                                   Zamora-Ros et al., 2013
  Anthocyanins                            SU.VI.MAX                                French                              12.6                                                        59/2011         24.5 vs 56.9 (Q4)                            0.55 (0.23-1.27)                                                  0.08                                           Non-to-low alcohol users; increased risk in higher drinkers                                                                                              Touvier et al., 2013
  Anthocyanidins                          EPIC                                     Women from ten European countries   11.5                       Pre-                             2827/334850     \<12.1 vs \>43.6 (Q5)                        1.09 (0.93-1.28)                                                  0.323                                          NA                                                                                                                                                       Zamora-Ros et al., 2013
  Anthocyanidins                          CPS-II                                   American                            8.5                        Post-                            2116/56630      ≤5.3 vs \>16.1-97.9 (Q5)                     0.91 (0.80-1.05)                                                  0.52                                           No effect modification by ER status                                                                                                                      Wang et al., 2014
  Anthocyanidins                          EPIC                                     Women from ten European countries   11.5                       Post-                            5872/334850     \<12.1 vs \>43.6 (Q5)                        1.01 (0.90-1.13)                                                  0.829                                          NA                                                                                                                                                       Zamora-Ros et al., 2013

CPS-II, The Cancer Prevention Study II Nutrition Cohort; CTS, The California Teachers Study (USA); E3N, Etude Epidemiologique aupres de femmes de la Mutuelle Generale de l´Education Nationale; EPIC, The European Prospective Investigation into Cancer and Nutrition; FMC, The Finnish Mobile Clinic Health Examination Survey; IWHS, The Iowa Women\`s Health Study; JPHC, The Japan Public Health Center-based prospective study; MEC, The Multiethnic Cohort Study; NHS II, The Nurses Health Study II; NLCS, The Netherlands Cohort Study; RS, The Rotterdam Study; SCHS, The Singapore Chinese Health Study; SU.VI.MAX, The Supplementation en Vitamines et Mineraux AntioXydants study; SWHS, The Shanghai Women\`s Health Study; TS, The Takayama Study; WHS, The Women\`s Health Study; WLH, The Scandinavian Women\`s Lifestyle and Health Cohort;bT3, tertiles; Q4, quartiles; Q5, quintiles;

OR, odds ratio; RR, relative risk; HR, hazard ratio;

Statistically significant effects (p for trend \<0.05) are marked by asterisk;

ER, estrogen receptor; HRT, hormone replacement therapy; PR, progesterone receptor; NA, not applicable.

###### 

Epidemiological Studies on Biomarkers of Flavonoids and Breast Cancer Risk

  Flavonoid subclass   Certain compound                 Bio-marker   Study^[a](#t3f1){ref-type="table-fn"}^   Population               Menopausal status   Cases/ controls   Multivariate-adjusted OR^[b](#t3f2){ref-type="table-fn"}^   P for trend^[c](#t3f3){ref-type="table-fn"}^   Comments^[d](#t3f4){ref-type="table-fn"}^                                                                                   Reference
  -------------------- -------------------------------- ------------ ---------------------------------------- ------------------------ ------------------- ----------------- ----------------------------------------------------------- ---------------------------------------------- --------------------------------------------------------------------------------------------------------------------------- ----------------------------
  Flavonols                                             Urinary      SWHS                                     Chinese                                      353/701           1.04 (0.73-1.48)                                            0.605                                          NA                                                                                                                          Luo et al., 2010
  Flavonols            Kaempferol                       Urinary      SWHS                                     Chinese                                      353/701           1.11 (0.77-1.60)                                            0.463                                          NA                                                                                                                          Luo et al., 2010
  Flavonols            Quercetin                        Urinary      SWHS                                     Chinese                                      353/701           1.01 (0.71-1.43)                                            0.74                                           NA                                                                                                                          Luo et al., 2010
  Flavanones           Citrus flavonoids                Urinary      SBCS                                     Chinese                                      250/250           1.04 (0.66-1.63)                                            0.86                                           NA                                                                                                                          Dai et al., 2002
  Flavanones           Citrus flavonoids                Urinary      SBCS                                     Chinese                  Pre-                132/132           1.53 (0.77-3.04)                                            0.27                                           NA                                                                                                                          Dai et al., 2002
  Flavanones           Citrus flavonoids                Urinary      SBCS                                     Chinese                  Post-               118/118           0.79 (0.41-1.51)                                            0.51                                           NA                                                                                                                          Dai et al., 2002
  Flavanones           Hesperetin                       Urinary      SBCS                                     Chinese                                      250/250           0.87 (0.54-1.39)                                            0.42                                           NA                                                                                                                          Dai et al., 2002
  Flavanones           Naringenin                       Urinary      SBCS                                     Chinese                                      250/250           1.02 (0.66-1.60)                                            0.92                                           NA                                                                                                                          Dai et al., 2002
  Flavanols            (-)-Epicatechin                  Plasma       JPHC                                     Japanese                                     144/288           0.95 (0.43-2.08)                                            0.86                                           NA                                                                                                                          Iwasaki et al., 2010
  Flavanols            (-)-Epicatechin                  Plasma       JPHC                                     Japanese                 Pre-                59/118            1.15 (0.43-3.11)                                                                                           NA                                                                                                                          Iwasaki et al., 2010
  Flavanols            (-)-Epicatechin                  Plasma       JPHC                                     Japanese                 Post-               80/160            1.11 (0.43-2.84)                                                                                           NA                                                                                                                          Iwasaki et al., 2010
  Flavanols            (-)-Epicatechin                  Urinary      SWHS                                     Chinese                                      353/701           1.01 (0.72-1.40)                                            0.564                                          NA                                                                                                                          Luo et al., 2010
  Flavanols            (-)-Epigallocatechin             Plasma       JPHC                                     Japanese                                     144/288           0.90 (0.42-1.96)                                            0.98                                           NA                                                                                                                          Iwasaki et al., 2010
  Flavanols            (-)-Epigallocatechin             Plasma       JPHC                                     Japanese                 Pre-                59/118            1.44 (0.58-3.58)                                                                                           NA                                                                                                                          Iwasaki et al., 2010
  Flavanols            (-)-Epigallocatechin             Plasma       JPHC                                     Japanese                 Post-               80/160            0.95 (0.42-2.18)                                                                                           NA                                                                                                                          Iwasaki et al., 2010
  Flavanols            (-)-Epigallocatechin             Urinary      SWHS                                     Chinese                                      353/701           0.88 (0.62-1.26)                                            0.344                                          NA                                                                                                                          Luo et al., 2010
  Flavanols            (-)-Epicatechin 3-gallate        Plasma       JPHC                                     Japanese                                     144/288           1.75 (0.81-3.78)                                            0.15                                           NA                                                                                                                          Iwasaki et al., 2010
  Flavanols            (-)-Epicatechin 3-gallate        Plasma       JPHC                                     Japanese                 Pre-                59/118            1.67 (0.62-4.50)                                                                                           NA                                                                                                                          Iwasaki et al., 2010
  Flavanols            (-)-Epicatechin 3-gallate        Plasma       JPHC                                     Japanese                 Post-               80/160            1.91 (0.72-5.07)                                                                                           NA                                                                                                                          Iwasaki et al., 2010
  Flavanols            (-)-Epigallocatechin 3-gallate   Plasma       JPHC                                     Japanese                                     144/288           1.21 (0.52-2.80)                                            0.53                                           NA                                                                                                                          Iwasaki et al., 2010
  Flavanols            (-)-Epigallocatechin 3-gallate   Plasma       JPHC                                     Japanese                 Pre-                59/118            1.78 (0.66-4.79)                                                                                           NA                                                                                                                          Iwasaki et al., 2010
  Flavanols            (-)-Epigallocatechin 3-gallate   Plasma       JPHC                                     Japanese                 Post-               80/160            1.22 (0.50-2.95)                                                                                           NA                                                                                                                          Iwasaki et al., 2010
  Isoflavones                                           Serum        EPIC-Norfolk                             English                                      219/891           1.03 (0.95-1.11)                                            0.479                                          No effect modification by ER+ status                                                                                        Ward et al., 2008
  Isoflavones                                           Urinary      SBCS                                     Chinese                                      60/60             0.50 (0.191.31)                                             0.11                                           NA                                                                                                                          Zheng et al., 1999
  Isoflavones                                           Urinary      SBCS                                     Chinese                                      250/250           0.62 (0.39-0.99)                                            0.04\*                                         NA                                                                                                                          Dai et al., 2002
  Isoflavones                                           Urinary      EPIC-Norfolk                             English                                      198/797           1.08 (1.00-1.16)                                            0.055                                          No effect modification by ER+ status                                                                                        Ward et al., 2008
  Isoflavones                                           Urinary      SBCS                                     Chinese                  Pre-                132/132           0.72 (0.36-1.44)                                            0.33                                           NA                                                                                                                          Dai et al., 2002
  Isoflavones                                           Urinary      EPIC-Norfolk                             English                  Pre- and peri-                        1.30 (1.04-1.64)                                            0.022\*                                        NA                                                                                                                          Ward et al., 2008
  Isoflavones                                           Urinary      SBCS                                     Chinese                  Post-               118/118           0.54 (0.28-1.06)                                            0.07                                           NA                                                                                                                          Dai et al., 2002
  Isoflavones                                           Urinary      EPIC-Norfolk                             English                  Post-                                 1.01 (0.96-1.13)                                            0.372                                          NA                                                                                                                          Ward et al., 2008
  Isoflavones                                           Urinary      SBCS                                     Chinese                  Post-               117/117           0.46 (0.22-0.95)                                            0.04\*                                         Significant inverse association only for women with BMI≥25, WHR≥0.84; blood E2\>5.73 pg/ml, E1-S≤0.96 ng/ml, SHBG≤81.4 nM   Dai et al., 2003
  Isoflavones          Genistein                        Plasma       EPIC Dutch                               Dutch                                        388/388           0.68 (0.47-0.98)                                            0.07                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          Genistein                        Plasma       JPHC                                     Japanese                                     144/288           0.34 (0.16-0.74)                                            0.02\*                                         NA                                                                                                                          Iwasaki et al., 2008
  Isoflavones          Genistein                        Plasma                                                Chinese                                      188/982           0.26 (0.13-0.50)                                            0.0001\*                                       NA                                                                                                                          Lampe et al., 2007
  Isoflavones          Genistein                        Plasma       JPHC                                     Japanese                 Pre-                59/118            0.14 (0.03-0.69)                                            0.2                                            NA                                                                                                                          Iwasaki et al., 2008
  Isoflavones          Genistein                        Plasma       EPIC Dutch                               Dutch                    Pre- or peri-       87/87             0.80 (0.38-1.69)                                            0.65                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          Genistein                        Plasma       EPIC Dutch                               Dutch                    Post-               296/296           0.69 (0.45-1.04)                                            0.09                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          Genistein                        Plasma       JPHC                                     Japanese                 Post-               80/160            0.36 (0.12-1.12)                                            0.1                                            NA                                                                                                                          Iwasaki et al., 2008
  Isoflavones          Genistein                        Serum        EPIC-Norfolk                             English                                      97/187            1.237 (0.976-1.569)                                         0.077                                          NA                                                                                                                          Grace et al., 2004
  Isoflavones          Genistein                        Serum        EPIC-Norfolk                             English                                      219/891           1.00 (0.94-1.05)                                            0.911                                          No effect modification by ER+ status                                                                                        Ward et al., 2008
  Isoflavones          Genistein                        Urinary      EPIC-Norfolk                             English                                      114/219           1.162 (0.973-1.387)                                         0.097                                          NA                                                                                                                          Grace et al., 2004
  Isoflavones          Genistein                        Urinary      EPIC-Norfolk                             English                                      198/797           1.01 (0.97-1.05)                                            0.706                                          No effect modification by ER+ status                                                                                        Ward et al., 2008
  Isoflavones          Genistein                        Urinary      SBCS                                     Chinese                                      60/60             0.70 (0.27-1.84)                                            0.27                                           NA                                                                                                                          Zheng et al., 1999
  Isoflavones          Genistein                        Urinary      SBCS                                     Chinese                                      250/250           0.65 (0.41-1.03)                                            0.07                                           NA                                                                                                                          Dai et al., 2002
  Isoflavones          Genistein                        Urinary      MEC                                      American (multiethnic)   Post-               251/462           0.79 (0.49-1.28)                                            0.29                                           NA                                                                                                                          Goodman et al., 2009
  Isoflavones          Genistein                        Urinary      MEC                                      Japanese-American        Post-               112/216           0.62 (0.29-1.32)                                            0.08                                           NA                                                                                                                          Goodman et al., 2009
  Isoflavones          Genistein                        Urinary      MEC                                      American (white)         Post-               51/96             0.98 (0.35-2.73)                                            0.79                                           NA                                                                                                                          Goodman et al., 2009
  Isoflavones          Genistein                        Urinary      Prospective                              Dutch                    Post-               88/268            0.83 (0.46-1.51)                                            0.6                                            No effect modification by sample collection time before diagnosis                                                           den Tonkelaar et al., 2001
  Isoflavones          Dihydrogenistein                 Urinary      SBCS                                     Chinese                                      250/250           0.57 (0.36-0.90)                                            0.01\*                                         NA                                                                                                                          Dai et al., 2002
  Isoflavones          Daidzein                         Plasma       EPIC Dutch                               Dutch                                        388/388           0.83 (0.58-1.19)                                            0.33                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          Daidzein                         Plasma       JPHC                                     Japanese                                     144/288           0.71 (0.35-1.44)                                            0.54                                           NA                                                                                                                          Iwasaki et al., 2008
  Isoflavones          Daidzein                         Plasma                                                Chinese                                      176/956           0.23 (0.12-0.48)                                            \<0.0001\*                                     NA                                                                                                                          Lampe et al., 2007
  Isoflavones          Daidzein                         Plasma       JPHC                                     Japanese                 Pre-                59/118            0.49 (0.15-1.57)                                            0.48                                           NA                                                                                                                          Iwasaki et al., 2008
  Isoflavones          Daidzein                         Plasma       EPIC Dutch                               Dutch                    Pre- or peri-       87/87             0.80 (0.34-1.88)                                            0.44                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          Daidzein                         Plasma       EPIC Dutch                               Dutch                    Post-               296/296           0.88 (0.59-1.32)                                            0.59                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          Daidzein                         Plasma       JPHC                                     Japanese                 Post-               80/160            1.16 (0.43-3.15)                                            0.95                                           NA                                                                                                                          Iwasaki et al., 2008
  Isoflavones          Daidzein                         Serum        EPIC-Norfolk                             English                                      97/187            1.220 (1.005-1.481)                                         0.044\*                                        NA                                                                                                                          Grace et al., 2004
  Isoflavones          Daidzein                         Serum        EPIC-Norfolk                             English                                      219/891           1.04 (0.98-1.10)                                            0.225                                          No effect modification by ER+ status                                                                                        Ward et al., 2008
  Isoflavones          Daidzein                         Urinary                                               Australian                                   144/144           0.47 (0.17-1.33)                                            0.241                                          NA                                                                                                                          Ingram et al., 1997
  Isoflavones          Daidzein                         Urinary      EPIC-Norfolk                             English                                      114/219           1.123 (0.963-1.309)                                         0.138                                          NA                                                                                                                          Grace et al., 2004
  Isoflavones          Daidzein                         Urinary      EPIC-Norfolk                             English                                      198/797           1.05 (0.99-1.10)                                            0.096                                          No effect modification by ER+ status                                                                                        Ward et al., 2008
  Isoflavones          Daidzein                         Urinary      SBCS                                     Chinese                                      60/60             0.54 (0.22-1.32)                                            0.12                                           NA                                                                                                                          Zheng et al., 1999
  Isoflavones          Daidzein                         Urinary      SBCS                                     Chinese                                      250/250           0.54 (0.34-0.85)                                            \<0.01\*                                       NA                                                                                                                          Dai et al., 2002
  Isoflavones          Daidzein                         Urinary      MEC                                      American (multiethnic)   Post-               251/462           0.76 (0.47-1.21)                                            0.07                                           NA                                                                                                                          Goodman et al., 2009
  Isoflavones          Daidzein                         Urinary      MEC                                      Japanese-American        Post-               112/216           0.41 (0.19-0.89)                                            0.005\*                                        NA                                                                                                                          Goodman et al., 2009
  Isoflavones          Daidzein                         Urinary      MEC                                      American (white)         Post-               51/96             1.22 (0.46-3.22)                                            0.63                                           NA                                                                                                                          Goodman et al., 2009
  Isoflavones          Dihydrodaidzein                  Urinary      SBCS                                     Chinese                                      250/250           0.73 (0.47-1.14)                                            0.08                                           NA                                                                                                                          Dai et al., 2002
  Isoflavones          Glycitein                        Plasma       EPIC Dutch                               Dutch                                        388/388           0.83 (0.59-1.18)                                            0.32                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          Glycitein                        Plasma       EPIC Dutch                               Dutch                    Pre- or peri-       87/87             0.92 (0.42-2.03)                                            0.85                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          Glycitein                        Plasma       EPIC Dutch                               Dutch                    Post-               296/296           0.81 (0.53-1.04)                                            0.34                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          Glycitein                        Serum        EPIC-Norfolk                             English                                      97/187            1.226 (0.946-1.588)                                         0.123                                          NA                                                                                                                          Grace et al., 2004
  Isoflavones          Glycitein                        Serum        EPIC-Norfolk                             English                                      219/891           1.03 (0.97-1.10)                                            0.345                                          No effect modification by ER+ status                                                                                        Ward et al., 2008
  Isoflavones          Glycitein                        Urinary      EPIC-Norfolk                             English                                      114/219           1.076 (0.869-1.333)                                         0.499                                          NA                                                                                                                          Grace et al., 2004
  Isoflavones          Glycitein                        Urinary      EPIC-Norfolk                             English                                      198/797           1.03 (0.98-1.07)                                            0.248                                          No effect modification by ER+ status                                                                                        Ward et al., 2008
  Isoflavones          Glycitein                        Urinary      SBCS                                     Chinese                                      60/60             0.41 (0.15-1.11)                                            0.06                                           NA                                                                                                                          Zheng et al., 1999
  Isoflavones          Glycitein                        Urinary      SBCS                                     Chinese                                      250/250           0.42 (0.25-0.70)                                            \<0.01\*                                       NA                                                                                                                          Dai et al., 2002
  Isoflavones          O-Desmethylangolensin            Plasma       EPIC Dutch                               Dutch                                        388/388           0.83 (0.59-1.18)                                            0.39                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          O-Desmethylangolensin            Plasma       EPIC Dutch                               Dutch                    Pre- or peri-       87/87             0.66 (0.26-1.65)                                            0.32                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          O-Desmethylangolensin            Plasma       EPIC Dutch                               Dutch                    Post-               296/296           0.82 (0.55-1.23)                                            0.64                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          O-Desmethylangolensin            Serum        EPIC-Norfolk                             English                                      97/187            1.140 (0.933-1.393)                                         0.199                                          NA                                                                                                                          Grace et al., 2004
  Isoflavones          O-Desmethylangolensin            Serum        EPIC-Norfolk                             English                                      219/891           1.03 (0.97-1.09)                                            0.39                                           No effect modification by ER+ status                                                                                        Ward et al., 2008
  Isoflavones          O-Desmethylangolensin            Urinary      EPIC-Norfolk                             English                                      114/219           1.148 (0.930-1.417)                                         0.198                                          NA                                                                                                                          Grace et al., 2004
  Isoflavones          O-Desmethylangolensin            Urinary      EPIC-Norfolk                             English                                      198/797           1.02 (0.98-1.06)                                            0.25                                           No effect modification by ER+ status                                                                                        Ward et al., 2008
  Isoflavones          O-Desmethylangolensin            Urinary      SBCS                                     Chinese                                      250/250           0.72 (0.45-1.16)                                            0.15                                           NA                                                                                                                          Dai et al., 2002
  Isoflavones          Equol                            Plasma       EPIC Dutch                               Dutch                                        388/388           0.87 (0.63-1.21)                                                                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          Equol                            Plasma       EPIC Dutch                               Dutch                    Pre- or peri-       87/87             0.81 (0.39-1.69)                                                                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          Equol                            Plasma       EPIC Dutch                               Dutch                    Post-               296/296           0.91 (0.63-1.33)                                                                                           NA                                                                                                                          Verheus et al., 2007
  Isoflavones          Equol                            Serum        EPIC-Norfolk                             English                                      97/187            1.455 (1.051-2.017)                                         0.024\*                                        NA                                                                                                                          Grace et al., 2004
  Isoflavones          Equol                            Serum        EPIC-Norfolk                             English                                      219/891           1.04 (0.98-1.10)                                            0.167                                          No effect modification by ER+ status                                                                                        Ward et al., 2008
  Isoflavones          Equol                            Urinary                                               Australian                                   144/144           0.27 (0.10-0.69)                                            0.009\*                                        NA                                                                                                                          Ingram et al., 1997
  Isoflavones          Equol                            Urinary      EPIC-Norfolk                             English                                      114/219           1.344 (1.063-1.699)                                         0.013\*                                        NA                                                                                                                          Grace et al., 2004
  Isoflavones          Equol                            Urinary      EPIC-Norfolk                             English                                      198/797           1.03 (0.99-1.06)                                            0.131                                          A significant association for ER+ tumors (OR 1.07, 95% CI 1.01-1.12; P for trend 0.013)                                     Ward et al., 2008
  Isoflavones          Equol                            Urinary      MEC                                      American (multiethnic)   Post-               251/462           0.99 (0.62-1.56)                                            0.8                                            NA                                                                                                                          Goodman et al., 2009
  Isoflavones          Equol                            Urinary      MEC                                      Japanese-American        Post-               112/216           1.32 (0.70-2.49)                                            0.06                                           NA                                                                                                                          Goodman et al., 2009
  Isoflavones          Equol                            Urinary      MEC                                      American (white)         Post-               51/96             0.27 (0.08-0.95)                                            0.07                                           NA                                                                                                                          Goodman et al., 2009

EPIC; The European Prospective Investigation into Cancer and Nutrition; JPHC, The Japan Public Health Center-based prospective study; MEC, The Multiethnic Cohort Study; SBCS, The Shanghai Breast Cancer Study; SWHS, The Shanghai Women\`s Health Study;

OR; odds ratio;

Statistically significant effects (p for trend \<0.05) are marked by asterisk;

BMI; body mass index; E1-S, estrone sulfate; E2, estradiol; ER, estrogen receptor; NA, not applicable; SHBG, sex hormone-binding globulin; WHR, waist-to-hip ratio

Dietary intake of flavonoids and breast cancer risk {#sec2-1}
---------------------------------------------------

Summaries of epidemiological data measured by case-control and prospective cohort study design on associations between dietary flavonoids intake and breast cancer risk are presented in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, respectively. Fink (2007) indicated in a case-control study with American population that an increased consumption of total flavonoids, flavones, flavonols and flavanols, but not flavanones and anthocyanidins, was associated with a decreased breast cancer risk that was restricted only to postmenopausal (not premenopausal) women, whereas estrogen receptor (ER) and progesterone receptor (PR) status of tumor did not modify the findings. These outcomes were compatible with the results of two previous case-control studies conducted in Italy and Greece reporting a decrease in breast cancer risk with increasing intake of flavones (Peterson et al., 2003; Bosetti et al., 2005) and flavonols (Bosetti et al., 2005), but not other flavonoid subclasses, including flavanones, flavanols and anthocyanidins (Peterson et al., 2003; Bosetti et al., 2005). Moreover, the more recent findings of Torres-Sanchez (2009) in Mexican population also confirmed the protective effect of high dietary consumption of flavones and flavonols against breast cancer, especially among postmenopausal women ([Table 1](#T1){ref-type="table"}).

Nevertheless, the results from prospective cohort studies were not so promising concerning the chemopreventive activities of flavonoids. Indeed, no protective effects against overall breast tumorigenesis were shown for increased intake of total flavonoids in different populations (American, Dutch, Finnish) or stratifying cases by menopausal or hormone receptor (ER/PR) status (Knekt et al., 1997; Goldbohm et al., 1998; Knekt et al., 2002; Wang et al., 2009; Zamora-Ros et al., 2013; Wang et al., 2014; Pantavos et al., 2015). These findings were similar also for flavonoid subgroups, i.e. for flavones (Zamora-Ros et al., 2013), flavonols (Goldbohm et al., 1998; Knekt et al., 2002; Adebamowo et al., 2005; Zamora-Ros et al., 2013; Wang et al., 2014), flavanones (Knekt et al., 2002; Zamora-Ros et al., 2013; Wang et al., 2014), flavanols (Arts et al., 2002; Zamora-Ros et al., 2013; Wang et al., 2014), and anthocyanidins (Zamora-Ros et al., 2013). However, in a recent prospective cohort study, Touvier (2013) still described an inverse association between an increased consumption of total flavonoids, flavonols and flavanols and breast cancer risk in French non-to-low alcohol drinkers, although the number of cases (59) was rather small. Somewhat surprisingly, a positive association of total flavonoids, flavanols and anthocyanidins with breast cancer risk was found in this work for women with moderate-to-heavy alcohol intake indicating that some subclasses of polyphenols can possibly elevate the susceptibility to mammary tumorigenesis among women with high daily alcohol use. The possibility can still not be excluded that these findings reflect the well-known deleterious action of alcohol on breast carcinogenesis ([Table 2](#T2){ref-type="table"}).

The situation seems to be somewhat more delineated in the case of isoflavones. The findings of several case-control studies (Horn-Ross et al., 2001; Peterson et al., 2003; Bosetti et al., 2005; Fink et al., 2007; Cotterchio et al., 2008; Ward et al., 2010) and prospective cohort studies (Horn-Ross et al., 2002; Keinan-Boker et al., 2004; Touillaud et al., 2006; Hedelin et al., 2008; Travis et al., 2008; Zamora-Ros et al., 2013; Wang et al., 2014) demonstrated no associations (overall or stratifying by menopausal status) between isoflavone intake and breast cancer risk in different western populations (American, Canadian, Dutch, English, French, Greek, Italian, Swedish) where the habitual consumption of soy foods is rather low (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). It can be hypothesized that this intake level is probably too low to reveal any associations and in line with this assumption, dietary isoflavone intake was indeed related to a decreased breast cancer incidence in Asian countries with remarkably higher soy foods intake. In this way, modest inverse associations were observed in several case-control studies performed with Chinese (Zhang et al., 2009; Zhang et al., 2010; Zhu et al., 2011; Li et al., 2013), Japanese (Hirose et al., 2005; Iwasaki et al., 2008; Iwasaki et al., 2009a), Korean (Cho et al., 2010), Japanese Brazilian (Iwasaki et al., 2009a), Asian American (Wu et al., 2002) and South Asian women living in England (dos Santos Silva et al., 2004), and also in prospective cohort studies conducted with Chinese (Lee et al., 2009), Japanese (Yamamoto et al., 2003; Wada et al., 2013), Singapore Chinese (Wu et al., 2008), and Japanese American women (Morimoto et al., 2014). Further stratification of these results by menopausal status still revealed inconclusive outcomes: some studies showing protective effects of isoflavones only in premenopausal women (54-56% reduction in cancer risk) (Hirose et al., 2005; Lee et al., 2009; Zhang et al., 2010), some works restricting this advantageous action to postmenopausal women (26-68% reduction in cancer risk) (Yamamoto et al., 2003; Wu et al., 2008; Cho et al., 2010; Zhu et al., 2011; Wada et al., 2013) and others demonstrating the benefits for both menopausal strata (Zhang et al., 2009) (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). However, Linseisen (2004) suggested an association of dietary intake of two isoflavones, genistein and daidzein (but not total isoflavones), with a decreased breast cancer risk also in premenopausal German women despite a very low consumption of these compounds among German (0.15-0.16 mg/day) compared to Asian population (10-30 mg/day) (Tables [1](#T1){ref-type="table"}). The apparent protective effect of (high) isoflavone intake against breast carcinogenesis in premenopausal women can involve a decrease in serum estradiol level, suppression of gonadotropins surge in midcycle and lengthening the menstrual cycle (Zhang et al., 2010).

Besides the apparently essential role of daily amount of dietary isoflavone intake, also the timing of consumption of soy foods seems to be crucial. Indeed, Thanos (2006) suggested that higher intake of isoflavones during adolescence was related to significantly decreased risk of breast cancer among adult Canadian women ([Table 1](#T1){ref-type="table"}).

Biomarkers of flavonoids and breast cancer risk {#sec2-2}
-----------------------------------------------

Estimation of urinary and plasma/serum metabolites of flavonoids could potentially complement the epidemiological findings obtained from assessment of dietary intake by adding the bioavailability dimension of these compounds. The data about relationships between biomarkers and breast cancer risk are presented in [Table 3](#T3){ref-type="table"}. There were no statistically significant associations found for the level of urinary flavonols and flavanones or urinary and plasma flavanols with breast cancer risk in either Chinese or Japanese populations, irrespective of the menopausal status of women (Dai et al., 2002; Iwasaki et al., 2010; Luo et al., 2010) ([Table 3](#T3){ref-type="table"}). However, current results about relationships of urinary and circulating biomarkers of isoflavones and their metabolites with breast cancer incidence are still inconclusive and somewhat controversial. In this way, Dai (2002) reported about two-fold reduction in breast cancer risk in Chinese women with the highest versus lowest urinary excretion of both total isoflavones as well as genistein, daidzein, glycitein and their various metabolites, confirming the previous findings that rich consumption of soy foods might decrease the susceptibility toward breast carcinogenesis. At that, the inverse association between isoflavone excretion and cancer risk was somewhat stronger among postmenopausal women being even more evident among overweight females (Dai et al., 2002; Dai et al., 2003). Similarly, Zheng (1999) reported about half of breast cancer risk in Chinese women with the highest urinary excretion levels of total or individual isoflavones (genistein, daidzein, glycitein), although these results did not reach statistical significance probably because of a small sample size. Goodman (2009) described a decreased risk of breast cancer in postmenopausal Japanese American women with higher urinary excretion of daidzein and Ingram (1997) indicated almost four-fold reduction in breast tumor incidence in Australian women with high urinary levels of equol, a metabolite produced from daidzein. Furthermore, Lampe (2007) observed a remarkable reduction in the risk of both fibrocystic breast conditions as well as mammary cancer among Chinese women with high plasma concentrations of genistein and daidzein suggesting the anticancer effects of isoflavones already in early tumorigenesis. Reduction of breast cancer risk with increasing plasma levels of genistein (but not daidzein) was shown also among Japanese (Iwasaki et al., 2008) and Dutch women (Verheus et al., 2007) ([Table 3](#T3){ref-type="table"}).

On the contrary, Grace (2004) reported that high exposure to various isoflavones (genistein, daidzein, equol) exhibited even a positive relationship with breast cancer risk by increasing tumor incidence among English women. Although Ward (2008) demonstrated a marginal elevation of breast cancer risk with higher urinary concentrations of total isoflavones, being restricted to pre- and perimenopausal females, analysis by individual compounds (genistein, daidzein, glycitein) did not follow this trend. No considerable association of breast carcinogenesis was found also with urinary excretion of genistein in postmenopausal Dutch women in a prospective study design (den Tonkelaar et al., 2001) ([Table 3](#T3){ref-type="table"}).

Some reasons for inconsistencies {#sec2-3}
--------------------------------

The above described inconsistencies in associations between intake of flavonoids and breast cancer risk may be explained by several possible reasons. Comparison of different works is complicated due to the variation in estimation of exposure to these polyphenolic compounds as some investigations have assessed dietary intake and others measured biological markers. Evaluation through dietary consumption and measuring daily intake levels of flavonoids has been limited and difficult primarily because of lack of food composition tables (den Tonkelaar et al., 2001; Peeters et al., 2003; Grace et al., 2004; Fink et al., 2007; Cotterchio et al., 2008; Hui et al., 2013; Touvier et al., 2013). Quantitative estimation of dietary consumption has been feasible only since 2003 when the US Department of Agriculture (USDA) released the analytical database for the content of five subclasses of flavonoids (flavones, flavonols, flavanones, flavanols and anthocyanidins) in selected food items; food composition data for isoflavones was available one year earlier, i.e. in 2002 (Peterson et al., 2003; Cotterchio et al., 2008; Hui et al., 2013). Recently, also the Phenol-Explorer database was made public to provide detailed composition data for subgroups of flavonoids (Touvier et al., 2013). However, current dietary assessment tools and information about intake of flavonoids are still rather incomplete as new products are introduced to the market and some food items find nontraditional applications (for instance, soy bars) (Fink et al., 2007; Nagata, 2010; Hui et al., 2013; Morimoto et al., 2014). In particular, intake of isoflavones can be underestimated, especially in populations with low habitual consumption of soy foods where addition of soy to processed foods may be unlisted (Trock et al., 2006; Cotterchio et al., 2008). Also, use of soy and soy components but also other herbal supplements as food additives raises further questions and is needed to take into account in future analyses (Linseisen et al., 2004; Zamora-Ros et al., 2013; Morimoto et al., 2014). Moreover, variations in flavonoid intakes between different studies can be explained not only by diverse dietary habits and personal preferences but also by the differences in flavonoid contents in certain food items (Linseisen et al., 2004; Zhang et al., 2010). Indeed, content of flavonoids in food products can substantially vary according to species, differences in cultivars, environmental conditions, geographic location, season, climatic conditions, storage conditions, level of ripeness at the harvest time, but also processing methods and food preparation processes (dos Santos Silva et al., 2004; Grace et al., 2004; Adebamowo et al., 2005; Fink et al., 2007; Iwasaki et al., 2010; Luo et al., 2010). Therefore, the adaptability of USDA flavonoid databases to the diet of European or Asian populations can be somewhat questionable (Bosetti et al., 2005) and possible errors in estimation of exposure to flavonoids through dietary intake must be taken into account in interpreting the association findings.

On the other hand, different findings from Asian and Western populations about relationship between consumption of isoflavones and breast cancer risk suggest that isoflavone intake may still affect mammary carcinogenesis but dose may play a crucial role (Adebamowo et al., 2005; Lampe et al., 2007; Xie et al., 2013). It is conceivable that isoflavone intake has to reach a certain amount (overcome the so-called threshold level) in order to produce benefits and intake of soy foods in Western populations is too low and insufficient to provide enough isoflavones to decrease the risk of breast cancer (Horn-Ross et al., 2001; dos Santos Silva et al., 2004; Bosetti et al., 2005; Lampe et al., 2007; Ward et al., 2008; Wada et al., 2013; Xie et al., 2013). Indeed, the daily intake of isoflavones among women in the United States and Europe is usually less than 3 mg, whereas older adults in China and Japan consume even 25-50 mg of isoflavones per day meaning that higher consumption levels among Western women are far below the lower doses in Asian women (Peeters et al., 2003; Messina et al., 2006; Cotterchio et al., 2008; Messina et al., 2008; Nagata, 2010; Dong and Qin, 2011; Zamora-Ros et al., 2013). Because of this high level and also large variation in soy food intake, Asian populations are ideal settings for estimation of the associations between isoflavone consumption and breast cancer risk (Yamamoto et al., 2003; Iwasaki et al., 2008; Lee et al., 2009; Taylor et al., 2009).

Given the difficulties to detect all flavonoids-containing foods and additives in the diet, the use of biomarkers, such as blood levels or urinary excretion, may provide a more relevant and precise measure to estimate flavonoid consumption than dietary assessment (den Tonkelaar et al., 2001; Verheus et al., 2007; Ward et al., 2008; Luo et al., 2010; Morimoto et al., 2014). Moreover, after intake, flavonoids undergo numerous metabolic conversions in the gastrointestinal tract by intestinal bacteria, as a result of which both parent polyphenols as well as their different conjugates reach circulation and target tissues, and are eventually excreted mainly in urine (Zheng et al., 1999; Dai et al., 2002; Peeters et al., 2003; Lampe et al., 2007; Travis et al., 2008; Luo et al., 2010). It is thus possible that the most abundant compounds in the diet are not necessarily the ones which enter into bloodstream (Touvier et al., 2013). However, currently available food composition databases do not consider the differences in degree of metabolism and absorption of polyphenols that may be a critical factor of exposure to these phytochemicals in understanding their health effects (Lampe et al., 2007; Touvier et al., 2013). Moreover, there can be a large interindividual variation in absorption and excretion of flavonoids after ingestion, depending besides the amount and frequency of intake also on the microbial communities of gut, stress, possible bowel diseases, use of antibiotics (which affect the intestinal microflora), food matrix and background diet, endogenous hormones, or even on genetics and ethnicity (den Tonkelaar et al., 2001; Dai et al., 2002; dos Santos Silva et al., 2004; Kumar et al., 2004; Adebamowo et al., 2005; Trock et al., 2006; Verheus et al., 2007; Hedelin et al., 2008; Luo et al., 2010; Nagata, 2010). Indeed, the interindividual urinary excretion of total isoflavones was shown to vary 16-fold after ingestion of foods rich in soy products and the level of some metabolites can fluctuate even more (Dai et al., 2002). Furthermore, the bioactivities of parent compounds and metabolites can differ. For instance, equol is exclusively the metabolite produced from dietary isoflavone daidzein by certain intestinal bacteria. Only about 30-50 % of individuals are able to generate equol in response to dietary exposure to daidzein, whereas Asian subjects tend to be more likely toward this conversion than Western populations (Keinan-Boker et al., 2004; Linseisen et al., 2004; Lampe et al., 2007; Verheus et al., 2007; Iwasaki et al., 2008; Ward et al., 2008; Cho et al., 2010; Nagata, 2010). This higher prevalence of equol producers among Asian women might add one more explanation also to the beneficial effects of soy foods intake in terms of decreased susceptibility to breast carcinogenesis (Nagata, 2010). At that, equol exerts greater biological activity (including estrogenic action) than daidzein and is a much stronger antioxidant than all other isoflavones; therefore, only subjects who are equol producers experience these benefits (Keinan-Boker et al., 2004; Linseisen et al., 2004; Iwasaki et al., 2008; Cho et al., 2010; Nagata, 2010; Dong and Qin, 2011; Kang et al., 2012).

Although the use of biomarkers (plasma concentrations and urinary excretion) that integrate dietary consumption, metabolism and bioavailability of flavonoids may be more accurate, informative and attractive measure than dietary assessment, it primarily reflects the intake levels of flavonoid-containing foods only over a very short period (for instance, the half-lives of isoflavones in plasma are 6-8 h and almost all are excreted within 24-96 h after ingestion) (Ingram et al., 1997; Zheng et al., 1999; den Tonkelaar et al., 2001; Dai et al., 2002; Peeters et al., 2003; dos Santos Silva et al., 2004; Messina et al., 2006; Lampe et al., 2007; Iwasaki et al., 2008; Goodman et al., 2009). Therefore, recent diet may have a major impact on the levels of urinary polyphenols revealing also a large intraindividual variability within the time of day and timing regarding to meals (Zheng et al., 1999; Dai et al., 2002; Trock et al., 2006; Iwasaki et al., 2008; Iwasaki et al., 2010; Chen et al., 2014). Even though the consumption of flavonoids-containing foods is a personal dietary and habitual preference and these intake levels are relatively stable over time for most individuals, it is possible that breast cancer cases have altered their eating habits after cancer diagnosis or modified their diets just before sample collection (Zheng et al., 1999; den Tonkelaar et al., 2001; Lampe et al., 2007; Luo et al., 2010; Chen et al., 2014). In several epidemiological studies, only a single spot urine or one plasma sample were measured and these parameters may not reflect and represent the usual long-term human exposure levels (Trock et al., 2006; Luo et al., 2010). The possibilities of metabolic changes in biotransformation of flavonoids developed in consequence of breast carcinogenesis can also be not excluded (den Tonkelaar et al., 2001; Peterson et al., 2003; Iwasaki et al., 2008).

An additional factor possibly affecting the association between dietary intake of flavonoids (isoflavones) and breast cancer risk may come from the timing of consumption of isoflavone-rich food items (Travis et al., 2008; Morimoto et al., 2014). The protective effect of soy foods intake reported in several Asian studies can be related to the early life or continuous long-term exposure to isoflavones (Keinan-Boker et al., 2004; Travis et al., 2008; Dong and Qin, 2011; Kang et al., 2012; Wada et al., 2013; Xie et al., 2013; Zamora-Ros et al., 2013). Consumption of isoflavones in higher amounts since childhood or adolescence (prepubertally) may affect the maturation of mammary gland and therefore influence also the risk of breast cancer incidence in later life (Thanos et al., 2006; Lampe et al., 2007; Ward et al., 2008; Nagata, 2010; Xie et al., 2013). Because of majority of Western women have not experienced sufficient early-life exposure to soy foods the beneficial health effects could not be expressed (Morimoto et al., 2014). However, it is difficult to decide whether recent dietary intake of flavonoids can reflect the intake patterns during the time periods which are most relevant to tumor initiation and development, making it possible that these age intervals were missed in several epidemiological studies (Keinan-Boker et al., 2004; Adebamowo et al., 2005; Fink et al., 2007; Ward et al., 2008). In future, it would be interesting to study the effects of in utero exposure to isoflavones through maternal soy consumption on breast cancer risk in older age.

The power to draw consequences in epidemiological studies can be limited due to the small numbers of participants, particularly in the stratified analyses with restricted subgroups (Adebamowo et al., 2005; Cho et al., 2010; Zhu et al., 2011). Some variations in the findings of risk association can be attributed to the differences in study design, i.e. case-control versus prospective cohort studies. Interpretation of results from case-control studies are typically more complicated as reported parameters among cases might have influenced by disease, both directly inducing metabolic alterations or indirectly through dietary changes or stress (dos Santos Silva et al., 2004). Therefore, any case-control studies suffer several potential limitations, including recall bias as cancer patients may describe their dietary habits differently than controls (Horn-Ross et al., 2002; Thanos et al., 2006; Cotterchio et al., 2008; Iwasaki et al., 2009a; Cho et al., 2010; Dong and Qin, 2011; Zamora-Ros et al., 2013). This study design is susceptible also to selection bias that can still be avoided by proper choosing of cases and controls from the same cohort (Trock et al., 2006; Cotterchio et al., 2008; Iwasaki et al., 2008; Dong and Qin, 2011). Selection of controls from non-cancer inpatients or outpatients in hospital can involve some measurement errors because of their different dietary habits compared to the general population (Hirose et al., 2005; Zhang et al., 2010; Li et al., 2013). In addition, the possibility still remains that control subjects who voluntarily agree to participate might be more conscious of healthy eating and lifestyle than the general population of females not suffering from breast cancer (Ingram et al., 1997; den Tonkelaar et al., 2001; Trock et al., 2006). Prospective cohort study design has several preferences being free from differential bias in reported dietary data, since information of consumption is collected before breast cancer diagnosis (Yamamoto et al., 2003; Iwasaki et al., 2010; Wada et al., 2013; Morimoto et al., 2014). Also, longer-term follow-up periods can be applied in these large-scale studies. However, estimating the flavonoids intake only once in baseline of study can entail measurement errors in those participants who alter their dietary patterns during follow-up years. Moreover, patients could have modified their dietary habits during early prediagnostic period due to preclinical signs of disease (Wada et al., 2013; Zamora-Ros et al., 2013).

While many probable confounders were considered in the association studies between intake of flavonoids and breast cancer risk, confounding by other known and unknown factors cannot be fully excluded (Peterson et al., 2003; Yamamoto et al., 2003; dos Santos Silva et al., 2004; Grace et al., 2004; Cotterchio et al., 2008; Iwasaki et al., 2008; Wada et al., 2013; Wang et al., 2014). It is possible that abundant consumption of flavonoids-containing food items (such as fruits and vegetables) may be associated with an overall healthy diet and lifestyle or ingestion of other anticancer substances, or be a marker for other characteristics related to susceptibility toward mammary carcinogenesis (Thanos et al., 2006; Fink et al., 2007; Lee et al., 2009; Dong and Qin, 2011; Xie et al., 2013). Regarding to the effects of isoflavones being often evaluated by the consumption of soy foods, other bioactive constituents in soy may also exert beneficial action on breast cancer risk (Bouker and Hilakivi-Clarke, 2000; Wu et al., 2002; Cho et al., 2010). In addition, in several epidemiological studies the information about expression of estrogen and progesterone receptors in tumor tissue as well as the menopausal or equol-producer status of participants are unknown, although these factors can potentially modify the relationships between flavonoids and breast cancer (Travis et al., 2008; Dong and Qin, 2011; Hui et al., 2013; Wada et al., 2013; Chen et al., 2014). It has been hypothesized that isoflavones act as estrogen receptor agonists in low-endogenous-estrogen conditions typical for postmenopausal women and as antagonists in high-endogenous-estrogen environment observed in premenopausal women (Fink et al., 2007; Cho et al., 2010; Nagata, 2010; Dong and Qin, 2011; Wada et al., 2013). Although, findings of epidemiological studies are inconclusive, greater impact among postmenopausal women can suggest that emerging of effect through habitual dietary consumption of isoflavones can take a long time (Fink et al., 2007; Cho et al., 2010; Hui et al., 2013; Wada et al., 2013). Also, premenopausal and postmenopausal breast tumors may have separate disease etiologies and the biological role of flavonoids in breast carcinogenesis may be mediated by mechanisms involving the synthesis of sex hormones in ovaries or alteration of other characteristics of menstrual cycle (Travis et al., 2008; Zhang et al., 2010; Zhu et al., 2011; Hui et al., 2013; Zamora-Ros et al., 2013). The dependence of isoflavones activity on hormonal milieu is reflected also by stratification of association findings according to obesity characteristics, i.e. body mass index (BMI) and waist-to-hip ratio (WHR) (Iwasaki et al., 2008). Besides hormonal effects, flavonoids exert also antioxidant, antiproliferative, antiangiogenic and anti-inflammatory activities, all of which, singly or combined, can contribute to the protective action of these phytochemicals against breast carcinogenesis (Iwasaki et al., 2009a; Hui et al., 2013; Wada et al., 2013).

Last but not least, inconsistencies in the epidemiological findings about associations between intake of flavonoids and breast cancer risk may be explained also by diet-gene interactions (Hedelin et al., 2008; Zhang et al., 2009; Cho et al., 2010). Although this knowledge is still rather scarce today, the protective effect of isoflavones against mammary tumorigenesis was limited only to those postmenopausal Japanese, Japanese Brazilian and non-Japanese Brazilian women who carried the GG genotype of the rs4986938 single nucleotide polymorphism in the estrogen receptor beta (ESR2) gene (Iwasaki et al., 2009b). Also, the genetic variations in DNA repair genes may modify the protective action of isoflavones on breast cancer (Khankari et al., 2014).

Conclusions and further perspectives {#sec2-4}
------------------------------------

Despite numerous experimental data demonstrating anticancer action of flavonoids *in vitro* conditions and animal experiments (Sak, 2014), epidemiological findings about the association between intake of these plant-based polyphenols and breast cancer risk have produced inconsistent results. The heterogeneity between findings of different studies can be caused by various reasons, including the study design (retrospective works are sensitive to recall bias, differently from prospective studies), dose and timing of exposure to flavonoids, menopausal status of women, and subtype of breast tumor.

The current review demonstrates that probably the most apparent relationship prevails for consumption of isoflavones, whereas beneficial effects seem to be expressed only at high intake levels typical to Asian women providing some explanations also to the reduced incidence rate of mammary tumors in Asian populations compared to Western countries where the intake of soy products is remarkably low. Moreover, protective activities of isoflavones might appear only in females consuming soy foods since their early age as childhood and adolescence can be crucial periods of exposure. Therefore, consumption of dietary phytochemicals could play a significant protective role against breast carcinogenesis and if confirmed, these findings increase the attractiveness to use isoflavones-containing food items as potential chemopreventive agents and suggest also the importance to initiate the cancer prevention at early age. As diet is a potentially modifiable factor in our life, the conclusions of this review may have significant implications for public health and can be used also by healthcare professionals in consulting the patients on prevention of breast tumor. However, it is self-evident that before this, more large-scale studies are needed to further investigate the effects of dose and exposure timing to flavonoids, form and source of these phytochemicals, their potential mechanisms in carcinogenesis, impact of food matrix, interactions between diet and genes, ethnicity of participants, their good and bad health habits like smoking and alcohol consumption, role of specific tumor characteristics and level of endogenous hormones among several other more or less important factors. In the current stage, recommendations for consumption of high-dose isoflavones from food items or supplements to reduce the individual susceptibility toward breast carcinogenesis are still premature and can also be not completely without the risks.
